Breath-Measuring Device in Upcoming NHS Trials Could Monitor Recovery from Covid-19
Wide Blue 01 July 2020
Wideblue is working with NHS England on a clinical trial of its personal ‘capnometer’, and will be submitting its device in the next month. It could also help determine if a patient needs a ventilator.
Commissioned by Cambridge Respiratory Innovations Limited, the CRiL N-Tidal C is designed to measure exhaled carbon dioxide (CO2) in the breath, which is a good indicator of lung health. Hospitals usually do this with large capnometers, but the new device is designed to be low-cost and simple to use.
The N-Tidal, now in its second generation after six years of development, was initially aimed at people with asthma and chronic obstructive pulmonary disease.
